Atlas Trials

Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients

Clinical trial NCT01997983 · COMPLETED

Trial details

NCT number
NCT01997983
Sponsor
UroGen Pharma Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Interstitial CystitisIC
Start date
2013-11-01
Primary completion
2014-04-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.